Spyre Therapeutics
SYRE
SYRE
33 hedge funds and large institutions have $30.4M invested in Spyre Therapeutics in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+10
Holders Change %
+43.48%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
6
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Jennison Associates
New York
|
-$222K |
| 2 |
SCM
Sio Capital Management
New York
|
-$155K |
| 3 |
Squarepoint
New York
|
-$91K |
| 4 |
PA
Perceptive Advisors
New York
|
-$43K |
| 5 |
Renaissance Technologies
New York
|
-$42.3K |
